Product Categories
| Country: | China |
|---|---|
| Tel: | 021-65675885 |
| Mobile: | 18964387627 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| E64FC26 | C19H23F3O2 | 2285446-62-8 | Details |
| Nurr1 agonist 7 | C18H20O3 | 228707-95-7 | Details |
| Enpp-1-IN-16 | C23H32N4O4 | 2289739-47-3 | Details |
| NNC 92-1687 | C15H12N2O3S | 22903-37-3 | Details |
| VT103 | C18H17F3N4O2S | 2290608-13-6 | Details |
| Emzadirib | C27H40N4O6S2 | 2301085-04-9 | Details |
| Pocenbrodib | C28H32FN3O6 | 2304372-79-8 | Details |
| B-Raf IN 16 | C20H19N5O3S | 2304746-24-3 | Details |
| S2116 | C22H26ClF2N3O2 | 2262489-89-2 | Details |
| Datopotamab | 2267989-53-5 | Details |
| LDHA-IN-3 | C13H9F3Se | 227010-33-5 | Details |
| Pomalidomide 4'-PEG3-azide | C21H26N6O7 | 2271036-46-3 | Details |
| CP 461 | C25H22ClFN2O | 227619-96-7 | Details |
| FT206 | C25H29N5OS | 2278274-34-1 | Details |
| Apitegromab | 2278276-46-1 | Details |
| Polatuzumab | 2279068-37-8 | Details |
| SRD5A1-IN-1 | 2279077-93-7 | Details |
| S-Allylmercaptocysteine | C6H11NO2S2 | 2281-22-3 | Details |
| PI3K-IN-30 | C20H25F2N7O3 | 2281803-22-1 | Details |
| BGB-8035 | C24H31N5O4 | 2283349-24-4 | Details |
| MKK7-COV-9 | C18H16N4O2 | 2283355-59-7 | Details |
| MC2590 | C20H17N3O3 | 2284460-01-9 | Details |
| (R)-BDP9066 | C20H24N6 | 2284549-25-1 | Details |
| (S,R,S)-AHPC-O-Ph-PEG1-NH2 | C32H41N5O6S | 2361117-24-8 | Details |
| CCW16 | C22H20ClNO3 | 2361138-33-0 | Details |
| RIPK3-IN-1 | C29H25FN4O4 | 2361139-70-8 | Details |
| PI3K/mTOR Inhibitor-4 | C27H22FN3O6S | 2361215-32-7 | Details |
| VPC-70619 | C16H8ClF3N4O | 2361742-30-3 | Details |
| Succinate/succinate receptor antagonist 1 | C17H15N3O | 2361972-29-2 | Details |
| cRIPGBM chloride | C26H20ClFN2O2 | 2361988-77-2 | Details |
| Xininurad | C15H10Br2FN3O2 | 2365178-28-3 | Details |
| (E)-Ethyl 3-acetamidobut-2-enoate | C8H13NO3 | 23652-67-7 | Details |
| Cl-PEG6-acid | C14H27ClO8 | 2365309-92-6 | Details |
| Cap-dependent endonuclease-IN-1 | C27H22F2N2O6S | 2365473-17-0 | Details |
| Copper probe CF4 | C38H47F3N2O2S4 | 2365532-64-3 | Details |
| SK1- I hydrochloride | C17H28ClNO2 | 2366222-05-9 | Details |
| J30-8 | C17H9ClFN3O2S | 2366255-71-0 | Details |
| Tubulin inhibitor 11 | C22H23N3O3S | 2366260-33-3 | Details |
| Neogrifolin | C22H32O2 | 23665-96-5 | Details |
| N6-(p-Methoxybenzyl)adenosine | C18H21N5O5 | 23666-24-2 | Details |
| TMX-4100 | C11H10N4O2S | 2367619-63-2 | Details |
| FPFT-2216 | C12H12N4O3S | 2367619-87-0 | Details |
| Cbl-b-IN-5 | C17H17N5OS | 2368835-59-8 | Details |
| Cbl-b-IN-1 | C29H34N6O2 | 2368841-84-1 | Details |
| FHT-1015 | C25H25N5O4S3 | 2368903-18-6 | Details |
| Ponsegromab | 2368950-15-4 | Details |
| Socazolimab | 2305043-30-3 | Details |
| BPK-21 | C23H16Cl2F3NO2 | 2305052-77-9 | Details |
| BPK-25 | C21H17ClN4O2 | 2305052-86-0 | Details |
| Wnt/β-catenin agonist 1 | C22H25N3O2 | 2305372-67-0 | Details |
| IM-250 | C20H19F2N3O2S2 | 2305750-23-4 | Details |
| HBV-IN-4 | C24H19ClFN5O3 | 2305897-84-9 | Details |
| (Rac)-CP-601927 hydrochloride | 230615-01-7 | Details |
| LRRK2-IN-7 | C24H26N6O | 2307277-93-4 | Details |
| Boc-bipiperidine-ethynylbenzoic acid | C24H32N2O4 | 2308497-81-4 | Details |
| CP-544439 | C18H19FN2O6S | 230954-09-3 | Details |
| TRPC6-IN-3 | C22H22FN5O3 | 2311863-36-0 | Details |
| Sorbifolin | C16H12O6 | 23130-22-5 | Details |
| hnRNPK-IN-1 | C23H21N3O5 | 2313528-04-8 | Details |
| 17β-HSD10-IN-1 | 2316765-78-1 | Details |
| ERK5-IN-5 | 2318792-30-0 | Details |
| LysoTracker Red | C20H24BF2N5O | 231946-72-8 | Details |
| Anticancer agent 82 | C19H18Cl2N4O | 2319587-80-7 | Details |
| GYKI 52466 dihydrochloride | C17H16ClN3O2 | 2319722-40-0 | Details |
| LDC4297 hydrochloride | C23H29ClN8O | 2319747-14-1 | Details |
| AZ7550 trimesylate salt | C28H35N7O5S | 2319837-99-3 | Details |
| HOE-S 785026 trihydrochloride | 2320308-12-9 | Details |
| EAD1 TFA(1644388-26-0 Free base) | C26H28Cl2F3N7O2 | 2320427-95-8 | Details |
| Protein kinase inhibitors 1 hydrochloride | C18H18ClN5O3S | 2321337-71-5 | Details |
| Lepzacitinib | 2321488-47-3 | Details |
| Ilaprazole sodium hydrate | C19H21N4NaO3S | 2322264-11-7 | Details |
| PI3Kα-IN-4 | C25H23ClFN5O5S | 2322293-83-2 | Details |
| Piperanine | C17H21NO3 | 23512-46-1 | Details |
| TGFβ1-IN-1 | C22H24N2O3 | 2348795-14-0 | Details |
| APX2039 | C20H15FN4O2 | 2342606-49-7 | Details |
| PROTAC IRAK4 ligand-1 | C29H27F3N6O6 | 2357108-39-3 | Details |
| Paltimatrectinib | C20H15F5N6 | 2353522-15-1 | Details |
| GSK143 dihydrochloride | C17H23ClN6O2 | 2341796-81-2 | Details |
| Samidorphan HCl | 2328045-02-7 | Details |
| FAK inhibitor 2 | C29H33F3N8O2S2 | 2354405-14-2 | Details |
| Dihydrozeatin | C10H15N5O | 23599-75-9 | Details |
| KRAS G12C inhibitor 16 | C24H21ClFN3O3 | 2349392-79-4 | Details |
| CTP Synthetase-IN-1 | C20H19F3N6O3S2 | 2338811-71-3 | Details |
| IDO1-IN-18 | C23H18F4N2O3 | 2328099-08-5 | Details |
| 3β-Acetoxyurs-12-en-11-one | C32H50O3 | 2348-66-5 | Details |
| Thalidomide 4'-oxyacetamide-alkyl-C2-amine hydrochloride | C17H19ClN4O6 | 2341841-02-7 | Details |
| Brotianide | C15H10Br2ClNO2S | 23233-88-7 | Details |
| Tusamitamab | 2349294-95-5 | Details |
| BAY-43-9695 | C22H25N3O4S | 233255-39-5 | Details |
| AS-85 | C26H28F3N5O3S2 | 2323623-80-7 | Details |
| (S)-PI3Kα-IN-4 | C25H23ClFN5O5S | 2322293-84-3 | Details |
| Cycloposine | C33H51NO7 | 23185-94-6 | Details |
| GNE-9278 | C21H27N5O3S | 2315311-83-0 | Details |
| PAC1R antagonist 1 | C17H17ClN6O2 | 2305204-24-2 | Details |
| BRD-8000.3 | C19H21BrN4O | 2365504-95-4 | Details |
| Zelasudil | C22H21F2N7O | 2365193-22-0 | Details |
| SFI003 | C19H17N5OS | 2361332-90-1 | Details |
| Guanoxabenz hydrochloride | C8H9Cl3N4O | 23256-40-8 | Details |
| RAS inhibitor Abd-7 | C23H25N3O3 | 2351843-48-4 | Details |
| CDK7-IN-2 | C26H39N7O3 | 2326428-19-5 | Details |
| Product Total： Product Page： | ||||
| 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 | ||||